Global /China /Industrials /Specialty Business Services /600721

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

600721

• SSE: 600721 • Delayed

8.43CNY -1.1%

1.25 USD

As of 15 June 2026, Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd has a market cap of $478.41M USD, ranking #15416 globally and #4823 in China. It ranks #3550 in the Industrials sector, and #351 in the Specialty Business Services industry.

Global Rank

15416

Country Rank

4823

Sector Rank

3550

Industry Rank

351

Key Stats

Market Cap

$478.41MUSD

3.24B CNY

Enterprise Value

$438.61MUSD

2.97B CNY

Revenue (TTM)

$52.92MUSD

358.59M CNY

EBITDA (TTM)

$7.77MUSD

52.56M CNY

Net Income (TTM)

$3.93MUSD

26.61M CNY

EBITDA Margin

15%

Profit Margin

7.4%

PE Ratio

121.7

PS Ratio

9.0

PB Ratio

4.0

EV/EBITDA

56.4

Company Profile

Country (HQ)

China

Sector

Industrials

Industry

Specialty Business Services

CEO

Hui Huang open_in_new

Employees

672

Founded

1959

Website

xjbhc.net open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.1%	-2.3%	-16%	-8.1%	-4.8%	-31%	27%	32%	124%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600721 新疆百花村医药集团股份有限公司 Class A ISIN: CNE000000KQ1 Shares Out.: Shares Outstanding: 384.548M¹ Shares Float: 284.332M² TV: TradingView: SSE: 600721 SA: Stock Analysis: SHA: 600721 YF: Yahoo Finance: 600721.SS GF: Google Finance: SHA: 600721 BA: Barron's: 600721 MS: Morningstar: XSHG: 600721	8.43 CNY	TV: TradingView: SSE: 600721 SA: Stock Analysis: SHA: 600721 YF: Yahoo Finance: 600721.SS GF: Google Finance: SHA: 600721 BA: Barron's: 600721 MS: Morningstar: XSHG: 600721

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers bioanalytical testing, packaging material compatibility, compound structure confirmation, quality studies, and base toxic impurity analysis. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.

Similar Companies

Industry: Specialty Business Services (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi XDC Cayman Inc. SHEK: 2268	$9.42B 73.79B HKD 2K%	47.0	China
Beijing Compass Technology Development Co., Ltd. SHE: 300803	$8.76B 59.36B CNY 2K%	296.1	China
TAL Education Group NYSE: TAL	$6.6B 1K%	11.8	China
Hui Lyu Ecological Technology Groups Co.,Ltd. SHE: 001267	$6.25B 42.34B CNY 1K%	480.6	China
Jiangsu Boqian New Materials Stock Co., Ltd. SSE: 605376	$4.62B 31.29B CNY 865%	128.4	China
Suzhou Tianmai Thermal Technology Co., Ltd. SHE: 301626	$4.6B 31.16B CNY 861%	163.3	China

Industry: Specialty Business Services (Global)

Name	Market Cap (USD) diff.	PE	Country
Shopify Inc. NASDAQ: SHOP	$158.14B 33K%	129.8	Canada
Verisure plc STO: VSURE	$132.68B 114.8B EUR 28K%	-	United Kingdom
Cintas Corp. NASDAQ: CTAS	$69.6B 14K%	36.8	United States
RELX PLC LSE: REL	$63.78B 47.6B GBP 13K%	23.9	United Kingdom
PayPal Holdings, Inc. NASDAQ: PYPL	$45.83B 9K%	9.4	United States
T Thomson Reuters Corp. NEO: TRI	$41.8B 56.91B CAD 9K%	-	Canada

chevron_leftBack